Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	56
Overall Study	STARTED	Lemborexant 1 Milligram (mg)	32
Overall Study	STARTED	Lemborexant 2.5 mg	27
Overall Study	STARTED	Lemborexant 5 mg	38
Overall Study	STARTED	Lemborexant 10 mg	32
Overall Study	STARTED	Lemborexant 15 mg	56
Overall Study	STARTED	Lemborexant 25 mg	50
Overall Study	COMPLETED	Placebo	51
Overall Study	COMPLETED	Lemborexant 1 Milligram (mg)	30
Overall Study	COMPLETED	Lemborexant 2.5 mg	27
Overall Study	COMPLETED	Lemborexant 5 mg	36
Overall Study	COMPLETED	Lemborexant 10 mg	30
Overall Study	COMPLETED	Lemborexant 15 mg	54
Overall Study	COMPLETED	Lemborexant 25 mg	45
Overall Study	NOT COMPLETED	Placebo	5
Overall Study	NOT COMPLETED	Lemborexant 1 Milligram (mg)	2
Overall Study	NOT COMPLETED	Lemborexant 2.5 mg	0
Overall Study	NOT COMPLETED	Lemborexant 5 mg	2
Overall Study	NOT COMPLETED	Lemborexant 10 mg	2
Overall Study	NOT COMPLETED	Lemborexant 15 mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01995838/flow